3E00XKZ
3E00XKZ — Introduction of Other Diagnostic Substance into Skin and Mucous Membranes, External Approach
Billable / specific codeICD-10-PCS
CMS abbreviated title: Introduce Oth Diagn Subst in Skin/Mucous Mem, Extern
How 3E00XKZ is built
Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.
- 3SectionAdministration — What family of procedure this is
- EBody systemWhich system it acts on
- 0Root operationThe objective — the verb of the procedure
- 0Body partThe specific site
- XApproachHow the site was reached
- KDeviceWhat was left in place, if anything
- ZQualifierA further distinction where one applies
Codes near 3E00XKZ
In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.
- 3E00X05Introduction of Other Antineoplastic into Skin and Mucous Membranes, External Approach
- 3E00X0MIntroduction of Antineoplastic, Monoclonal Antibody, into Skin and Mucous Membranes, External Approach
- 3E00X28Introduction of Oxazolidinones into Skin and Mucous Membranes, External Approach
- 3E00X29Introduction of Other Anti-infective into Skin and Mucous Membranes, External Approach
- 3E00X3ZIntroduction of Anti-inflammatory into Skin and Mucous Membranes, External Approach
- 3E00X4ZIntroduction of Serum, Toxoid and Vaccine into Skin and Mucous Membranes, External Approach
- 3E00XBZIntroduction of Anesthetic Agent into Skin and Mucous Membranes, External Approach
- 3E00XGCIntroduction of Other Therapeutic Substance into Skin and Mucous Membranes, External Approach
- 3E00XKZIntroduction of Other Diagnostic Substance into Skin and Mucous Membranes, External Approach
- 3E00XMZIntroduction of Pigment into Skin and Mucous Membranes, External Approach
- 3E00XNZIntroduction of Analgesics, Hypnotics, Sedatives into Skin and Mucous Membranes, External Approach
- 3E00XTZIntroduction of Destructive Agent into Skin and Mucous Membranes, External Approach
- 3E0102AIntroduction of Anti-Infective Envelope into Subcutaneous Tissue, Open Approach
- 3E01305Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach
- 3E0130MIntroduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach
- 3E01328Introduction of Oxazolidinones into Subcutaneous Tissue, Percutaneous Approach
- 3E01329Introduction of Other Anti-infective into Subcutaneous Tissue, Percutaneous Approach